Showing results (4811-4820 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 10, 2024
Evidence for the benefits of lifestyle medicine interventions in breast cancer survivorshipLaura E Wright, Preeti K Sudheendra
The Oncologist|November 19, 2024
Anthracyclines-induced cardiotoxicity in patients with early breast cancer carrying germline BRCA1/2 mutation: the BRCAN studyAlfonso Cortés-Salgado, Juan José Serrano, David Cordero Pereda, et al.
The Oncologist|November 19, 2024
Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanomaJeffrey Weber, Waqas Haque, Svetomir N Markovic, et al.
The Oncologist|November 26, 2024
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancerElena Castro, Rhett Figliuzzi, Sarah Walsh, et al.
The Oncologist|November 27, 2024
The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patientsAmr Radwan, Chinmay T Jani, Omar Al Omari, et al.
The Oncologist|November 16, 2024
Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 studyPilar García-Alfonso, Paula Jimenez-Fonseca, Javier Soto-Alsar, et al.
The Oncologist|October 14, 2024
Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastomaSimon Khagi, Rupesh Kotecha, Na Tosha N Gatson, et al.
The Oncologist|October 8, 2024
A rapid review of nutrition and exercise approaches to managing unintentional weight loss, muscle loss, and malnutrition in cancerBrenton J Baguley, Lara Edbrooke, Linda Denehy, et al.
The Oncologist|October 3, 2024
Is early-onset colorectal cancer an evolving pandemic? Real-world data from a tertiary cancer centerAngelos Angelakas, Thekla Christodoulou, Konstantinos Kamposioras, et al.
The Oncologist|September 28, 2024
Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy eraLior Apter, Sarah Sharman Moser, Sivan Gazit, et al.
Pageof 571